Hana Ř.
- Country
- Czechia
- Department
- Chronic pain
Research Overview
Data & Insights
Has run more than one trial at 0 of 83 partner sites.
Specializations
Neurodegenerative and Cognitive Disorders
Hana Řeháčková investigates therapeutic approaches for conditions such as Alzheimer’s disease and related behavioral disturbances, aiming to improve cognition and reduce agitation.
- Alzheimer’s disease
- Agitation associated with Alzheimer’s disease
- Alzheimer’s disease psychosis
- Mild cognitive impairment
- Cognitive impairment in Alzheimer’s disease
Her work emphasizes disease‑modifying strategies that address both neurodegeneration and neuropsychiatric symptoms.
Mood and Anxiety Disorders
She focuses on major depressive and anxiety conditions, including forms that are resistant to standard treatments, to enhance mood stability and reduce distress.
- Major depressive disorder
- Treatment‑resistant depression
- Anhedonia in depression
- Generalized anxiety disorder
- Depression with anxious distress
Research seeks adjunctive options that improve depressive symptomatology and anxiety control.
Headache and Migraine
Her investigations address both chronic and episodic migraine, exploring preventive and acute therapeutic options to lessen headache burden.
- Chronic migraine
- Episodic migraine
- Migraine without aura
- Migraine with aura
- Migraine prevention
Efforts target reduction of monthly migraine days and improvement of patient quality of life.
Chronic Pain and Low Back Pain
In the chronic pain domain, she evaluates interventions for chronic non‑specific low back pain when conventional non‑opioid therapies are insufficient.
- Chronic non‑specific low back pain
- Chronic pain
- Low back pain management
Her approach integrates multimodal analgesic strategies to achieve better pain control.
Movement Disorders, Seizures and Psychosis
She also contributes to studies on involuntary movement disorders, refractory seizures, and psychotic symptoms linked to neuropsychiatric illnesses.
- Tardive dyskinesia
- Refractory partial onset epilepsy
- Schizophrenia
- Psychosis associated with Alzheimer’s disease
Objectives include reducing dyskinetic movements, decreasing seizure frequency, and alleviating psychotic manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.